Bionano Genomics financials at a glance

+ Portfolio

The revenue of Bionano Genomics is reported as 0.03612 billion Dollars in the fiscal year 2023. The earnings were -6.81 Dollars per share in 2023, which was 48.04 lower than 2022. And about -0.12759 billion Dollars are reported as free cash flow in the financials of Bionano Genomics 2023. No dividends were paid to the shareholders of the Bionano Genomics stock NasdaqCM:BNGO in the financial year 2023.

$36.12M

Revenue

$-6.81

Earnings Per Share

26.49%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

36.12

Earnings Per Share

-6.81

Gross Margin %

26.49

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$36.12M	$27.80M	$17.98M	$8.50M	$10.13M	$12.00M
GM %	Gross Margin %	26.58%	26.49%	21.38%	21.54%	32.61%	33.18%	27.41%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-,255.44%	-,170.12%
EPS	Earnings Per Share	$-7.19	$-6.81	$-4.60	$-2.60	$-3.90	$-19.02	$-26.10
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	54.69M	30.62M	28.96M	27.87M	3.78M	1.01M
OCF	Operating Cash Flow	N/A	$-,125.18M	$-,124.82M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-,127.59M	$-,128.02M	$0.00M	$0.00M	$0.00M	$-20.28M
FCFS	Free Cash Flow Per Share	$-4.19	$-3.72	$-4.43	$-0.27	$-0.37	$-1.98	$-2.86

Bionano Genomics financials at a glance

Financials

Discover